Overview

This trial is active, not recruiting.

Condition diabetes mellitus
Treatments diabetes education via telemedicine, diabetes education in-person
Sponsor State University of New York - Upstate Medical University
Start date June 2001
End date June 2008
Trial size 68 participants
Trial identifier NCT00629434, UMU IRB # 4510F

Summary

This study compares group diabetes education in-person versus via telemedicine

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model parallel assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
This arm will receive diabetes education via telemedicine
diabetes education via telemedicine
This arm will receive diabetes group education via telemedicine
(Active Comparator)
diabetes education in-person
diabetes education in-person
In this arm the group of patients with diabetes will receive diabetes education in-person

Primary Outcomes

Measure
A1c
time frame: baseline, 3 mo post intervention, 6 mo post intervention

Secondary Outcomes

Measure
PAID scale
time frame: baseline, 3 and 6 months post intervention
Diabetes Treatment Satisfaction Questionnaire
time frame: Baseline, 3 and 6 months post intervention

Eligibility Criteria

Male or female participants from 18 years up to 85 years old.

Inclusion Criteria: - Type 1 or type 2 diabetes mellitus - age > 18 years Exclusion Criteria: - Profound vision loss - Severe hearing impairment

Additional Information

Official title A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
Description Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.
Trial information was received from ClinicalTrials.gov and was last updated in March 2008.
Information provided to ClinicalTrials.gov by State University of New York - Upstate Medical University.